SLShiying Ling

Shiying Ling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiying Ling has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Chaoshi Niu

    Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P.R. China

    1 shared publication
  • Fei Wang

    Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, Anhui Province, China

    1 shared publication
  • Fei Wang

    Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China

    1 shared publication
  • Jing-Jing Wu

    Second Affiliated Hospital of Anhui Medical University

    1 shared publication
  • Ming-Wu Li

    Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China

    1 shared publication
  • Shengyuan Ni

    The First Affiliated Hospital of USTC: Anhui Provincial Hospital

    1 shared publication

Latest Publications

  • Open Access

    Ectopic overexpression of GRK5 promotes malignant glioma progression closely associated with MSN-CD44 expression and glioma localization

    by Yang Yang, Zhiyu Xi, Jing-Jing Wu, Shengyuan Ni, Shiying Ling

    Background Gliomas are highly invasive and lack of effective targeted therapy. GRK5 is involved in several pathologic conditions including cancer. GRK5 phosphorylated MSN on T66 and regulated the subcellular distribution of MSN, which was a glioma progression marker that induces proliferation via interaction with CD44. Therefore, targeting GRK5-MSN-CD44 may provide a novel approach for the treatment of gliomas. Materials and methods GRK5-knockdown and GRK5-upregulated glioma cell lines were generated by using the lentivirus transfection method. The GRK5 and MSN expression and the association with the malignant characters in glioma were determined by Western blot and qRT-PCR. By using double-immunofluorescence and triple immunofluorescence analysis, the subcellular localization and distribution characteristics of GRK5-MSN-CD44 in gliomas were detected. The cell proliferation, migration, invasion and apoptosis were determined by CCK-8 assay, wound healing assay, transwell assay and flow cytometry respectively. Results GRK5 expression was up-regulated in human gliomas and positively correlated with MSN expression. GRK5-MSN and MSN-CD44 were found co-expressed in gliomas respectively. GRK5-MSN-CD44 were co-localized in the membrane of glioma cell and abundant in glioma stem cell niches. VEGF and N-cadherin expressions were increased/decreased according to the up-regulation/down-regulation of GRK5. And Bax expression showed decreased/increased according to GRK5 over-expression/low-expression. The proliferation, migration and invasion of glioma cells were improved due to the upregulation of GRK5. And the apoptosis of glioma cells was decreased/increased due to the up-regulation/down-regulation of GRK5. Conclusion Ectopic overexpression of GRK5 promoted the malignant progression of glioma and is closely related to MSN-CD44 interaction. GRK5-MSN-CD44 provides a new idea for gene targeted therapy of glioma.

  • Open Access

    Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics

    by Xuanzhi Wang, Mingwu Li, Xiaofeng Jiang, Fei Wang, Shiying Ling, Chaoshi Niu

    Objective: The Ki-67 index is an indicator of the active proliferation and aggressive behavior of pituitary adenomas (PAs). Appropriate pre- and intra-operatives of the Ki-67 index can help surgeons develop better and more personalized treatment strategies for patients with PAs. This study aimed to investigate the influence factors for predicting the Ki-67 index in PAs. Methods: Data of 178 patients with PAs confirmed by pathology were retrospectively analyzed. According to the Ki-67 index, the patients were divided into the Ki-67 < 3% and Ki-67 ≥ 3% cohorts. Patient data, including age, sex, postoperative immunohistochemical pituitary hormone positive index, Knosp grade, tumor breaking through the sellar floor, rich blood supply to the tumor, tumor located inside the sella, erosion of the dorsum sellae bone, and pituitary-specific transcription factor, were collected. A univariate logistic analysis was used to evaluate the influence factors for a high Ki-67 index. Multiple regression and receiver operating characteristic (ROC) curve were used to analyze the factors with p < 0.05. The mutant status of Ki-67 index was predicted by nomogram. Results: Multivariate regression analysis showed that rich blood supply to the tumor and erosion of the dorsum sellae bone were independent risk factors for the Ki-67 proliferation index. The ROC curves demonstrated that age, rich blood supply to the tumor, and erosion of the dorsum sellae bone can predict the occurrence of a high Ki-67 index. Together, the three risk factors provide a stronger ability to predict the Ki-67 index. The nomogram was developed and validated. Conclusion: Age, rich blood supply to the tumor, and erosion of the dorsum sellae bone are influencing factors for predicting the Ki-67 index. Suitable nomogram prediction models were developed and validated, and there is potential for personalized treatment for PA patients.